Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY – Get Free Report)’s share price gapped up prior to trading on Friday . The stock had previously closed at $10.51, but opened at $11.00. Ambu A/S shares last traded at $11.00, with a volume of 1,000 shares.
Ambu A/S Stock Up 4.7%
The company has a debt-to-equity ratio of 0.08, a current ratio of 2.92 and a quick ratio of 1.73. The business has a 50 day simple moving average of $10.35 and a 200 day simple moving average of $10.67. The stock has a market cap of $2.58 billion, a PE ratio of 39.29 and a beta of 0.93.
Ambu A/S (OTCMKTS:AMBBY – Get Free Report) last released its quarterly earnings results on Tuesday, August 25th. The company reported $0.09 earnings per share for the quarter. Ambu A/S had a net margin of 7.81% and a return on equity of 8.03%. The business had revenue of $255.12 million for the quarter.
About Ambu A/S
Ambu A/S is a Denmark-based medical device company specializing in single-use diagnostic and life-supporting equipment for hospitals, clinics and emergency services. The company’s core focus lies in developing products that enhance patient safety, streamline clinical workflows and reduce the risk of cross-contamination. Ambu’s offerings span critical care solutions such as anesthesia and respiratory care devices, as well as advanced endoscopy systems for minimally invasive diagnostics and therapies.
Within its anesthesia and respiratory care segment, Ambu is known for its market-leading disposable resuscitators—commonly referred to as “Ambu bags”—as well as a range of airway management products, including laryngeal masks and endotracheal tubes.
Read More
- Five stocks we like better than Ambu A/S
- Boeing’s $131B F-15 Win: Mach 1 Momentum or Just Altitude?
- Okta Stock Surges 29%—Is $200 the Next Stop?
- BWX Technologies’ Army Reactor Win Could Redraw Its Nuclear Growth Story
- Meta’s $18 Billion Settlement May Be a Win for Investors
Receive News & Ratings for Ambu A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambu A/S and related companies with MarketBeat.com's FREE daily email newsletter.
